Choom announced an initial agreement for the purchase of equity interest in an undisclosed New Jersey-based company seeking a retail license in the state for a medical dispensary.
Choom (CSE:CHOO,OTCQB:CHOOF) announced an initial agreement for the purchase of equity interest in an undisclosed New Jersey-based company seeking a retail license in the state for a medical dispensary.
As quoted in the press release:
The NJ Company is advancing on its retail store strategy in New Jersey with the intention of receiving licenses to operate the maximum allowable cannabis stores for medical and eventually adult use when formally approved by the State. With these licenses, the NJ Company intends to create a network of branded stores using Choom’s medical brand, Clarity Medical Centres, or Choom (“Choom Brands”) for its recreational retail stores in the future. Choom will assist the NJ Company in this highly regulated market for the buildout and operations of cannabis retail stores. Choom will receive a royalty from the NJ Company for the use of the Choom Brands. Choom’s investment in the NJ Company includes pro rata rights to maintain its equity interest on future financings.
“This is our first step into the United States, and we are very excited for our partnership with this experienced group to have the Choom Brands in New Jersey,” states Chris Bogart, President & CEO of Choom Holdings Inc.